You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-T%20Therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

Recruiting
  • CAR-T Therapy Complications
    • Bologna, Italy
      IRCC, University Hospital of Bologna
    Mar 18, 2022

    Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)

    Not yet recruiting
    • Peripheral T Cell Lymphoma
    • CAR-T Therapy
    • Hefei, Anhui, China
    • +7 more
    Jul 31, 2023

    Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Lymphoblastic Leukemia
    • CD19 Directed CAR T Cell
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 12, 2022

    Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

    Recruiting
    • Non-Hodgkin Lymphoma
    • Focal radiation therapy (RT)
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 8, 2022

    Lymphoma Trial in Seattle (biological, other, procedure)

    Not yet recruiting
    • Lymphoma
    • Immune Globulin Infusion (Human), 10% Solution
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2023

    Lymphoma, B-Cell Trial in Langfang (CD19 and CD22 targeted CAR-T cells)

    Not yet recruiting
    • Lymphoma, B-Cell
    • CD19 and CD22 targeted CAR-T cells
    • Langfang, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Dec 6, 2022

    Study of CAR-T Therapy in Older Patients

    Recruiting
    • Lymphoma
    • +5 more
    • Activities of Daily Living/ADLs
    • +10 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +2 more
    • Miami, Florida
      University of Miami
    Aug 3, 2022

    Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

    Recruiting
    • Hematologic Malignancy
    • Blood draw
    • Durham, North Carolina
      Duke University
    Jun 22, 2022

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023

    Multiple Myeloma, Relapse Multiple Myeloma Trial in Ramat Gan (CAR-BCMA)

    Recruiting
    • Multiple Myeloma
    • Relapse Multiple Myeloma
    • CAR-BCMA
    • Ramat Gan, Israel
      Chaim Sheba Medical Center, Tel Hashomer
    Feb 7, 2022

    CB-Long-Term Safety Study (CB-LTSS)

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
    • +7 more
    • Allogeneic CAR-T therapy
    • Irvine, California
    • +3 more
    Nov 18, 2022

    DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

    Recruiting
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Pembroke Pines, Florida
    • +3 more
    Jan 23, 2023

    Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

    Not yet recruiting
    • Lymphoma
    • +2 more
    • Web Application
    • San Francisco, California
      University of California, San Francisco
    Oct 4, 2022

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

    Not yet recruiting
    • Neuroendocrine Tumor (NET)
    • Colorectal Cancer (CRC)
    • CHM-2101 CAR-T cells
    • (no location specified)
    Sep 20, 2023

    Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)

    Recruiting
    • Gastric Cancer
    • +2 more
    • KD-496
    • Beijing, China
      Chinese PLA General Hospital
    Oct 13, 2022

    Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

    Active, not recruiting
    • Hematologic Malignancy
    • CAR-T Cell Therapy
    • Educational Video Tool
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 24, 2023

    Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma Trial in Jinan (CD70 CAR-T cells)

    Recruiting
    • Metastatic Tumor
    • +4 more
    • CD70 CAR-T cells
    • Jinan, Shandong, China
      The Second People's Hospital of Shandong Province
    Jun 14, 2022

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD19/CD22-bispecific CAR-T cells
    • Beijing, Beijing, China
      Liang Wang
    Oct 7, 2023

    CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

    Recruiting
    • CAR-T Cell Therapy
    • GC012F injection
    • Shanghai, Shanghai, China
      Department of Rheumatology, Ren Ji Hospital South Campus, School
    May 5, 2023

    Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Hangzhou (CEA CAR-T cells)

    Recruiting
    • Colorectal Cancer
    • +5 more
    • CEA CAR-T cells
    • Hangzhou, Zhejiang, China
      First affiliated hospital, Zhejiang University
    May 30, 2022

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023